Stocktoria
GRI Bio, Inc. GRI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-02-10
GRI Bio, Inc. statistics & valuation
Market cap$3.2M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -138.0% | -143.0% | -441.0% | -839.9% | -111.6% |
| Return on equity | -199.0% | -203.5% | -5033.6% | 198.0% | 191.9% |
| Current ratio | 3.25 | 3.43 | 1.09 | 0.16 | 3.32 |
| Revenue growth | — | — | — | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001824293 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.